Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Laminins affect T cell trafficking and allograft fate
Kristi J. Warren, … , Jonathan S. Bromberg, Bryna E. Burrell
Kristi J. Warren, … , Jonathan S. Bromberg, Bryna E. Burrell
Published April 1, 2014
Citation Information: J Clin Invest. 2014;124(5):2204-2218. https://doi.org/10.1172/JCI73683.
View: Text | PDF
Research Article Immunology

Laminins affect T cell trafficking and allograft fate

  • Text
  • PDF
Abstract

Lymph nodes (LNs) are integral sites for the generation of immune tolerance, migration of CD4+ T cells, and induction of Tregs. Despite the importance of LNs in regulation of inflammatory responses, the LN-specific factors that regulate T cell migration and the precise LN structural domains in which differentiation occurs remain undefined. Using intravital and fluorescent microscopy, we found that alloreactive T cells traffic distinctly into the tolerant LN and colocalize in exclusive regions with alloantigen-presenting cells, a process required for Treg induction. Extracellular matrix proteins, including those of the laminin family, formed regions within the LN that were permissive for colocalization of alloantigen-presenting cells, alloreactive T cells, and Tregs. We identified unique expression patterns of laminin proteins in high endothelial venule basement membranes and the cortical ridge that correlated with alloantigen-specific immunity or immune tolerance. The ratio of laminin α4 to laminin α5 was greater in domains within tolerant LNs, compared with immune LNs, and blocking laminin α4 function or inducing laminin α5 overexpression disrupted T cell and DC localization and transmigration through tolerant LNs. Furthermore, reducing α4 laminin circumvented tolerance induction and induced cardiac allograft inflammation and rejection in murine models. This work identifies laminins as potential targets for immune modulation.

Authors

Kristi J. Warren, Daiki Iwami, Donald G. Harris, Jonathan S. Bromberg, Bryna E. Burrell

×

Figure 8

Laminins α4 and α5 differentially modulate CD4+ T cell motility and transendothelial migration.

Options: View larger image (or click on image) Download as PowerPoint
Laminins α4 and α5 differentially modulate CD4+ T cell motility and tran...
Transwell membrane inserts (A–C) or laminar flow channels (D and E) were coated with indicated concentrations of laminin α4 and/or α5 overnight (A–C) or for 1 hour (D and E). MS-1 cells were added and grown to confluence in each apparatus. 0.5 μg CCL21 was added to the bottom chambers (A–C) or passed through laminar flow channels (D and E) immediately before each migration assay. (A) Percentage of CD4+ cells located in the top chamber (black bars) and bottom chamber (white bars) 4 hours after their addition to upper Transwell chambers. (B and C) Track length (B) and velocity (C) of CD4+ T cell migration over MS-1 cells acquired at 1-minute intervals for 30 minutes after addition of CD4+ T cells to the top Transwell chamber. (D) Adherence of CD4+ T cells to endothelial cells with (left panel) or without (right panel) CCL21 in laminar flow channels, imaged up to 50 minutes. (E) Transmigration of CD4+ T cells across endothelial cells in laminar flow channels with (left panel) and without (right panel) CCL21. Data presented as mean ± SEM. n = 4 replicates per experiment for 3 experiments. *P < 0.05, **P < 0.005, ***P < 0.0005. Lama 4/5, laminin α4/α5.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts